Results

Avid Bioservices Inc.

08/06/2020 | Press release | Distributed by Public on 08/06/2020 06:09

Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001